Home/Filings/4/0001012975-15-000251

4//SEC Filing

MEI Pharma, Inc. 4

Accession 0001012975-15-000251

$LITSCIK 0001262104operating

View on SEC.gov Company Profile

Filed

Mar 25, 8:00 PM ET

Accepted

Mar 26, 4:54 PM ET

Size

16.7 KB

Accession

0001012975-15-000251

Insider Transaction Report

Form 4

Period: 2015-03-24

MEI Pharma, Inc.MEIP

New Leaf Ventures II, L.P.

10% Owner

Transactions

Sale
Common Stock
2015-03-24$1.97/sh−1,601,390$3,160,183→ 0 total

HUNT RONALD

10% Owner

Transactions

Sale
Common Stock
2015-03-24$1.97/sh−1,601,390$3,160,183→ 0 total

Lathi Vijay K

10% Owner

Transactions

Sale
Common Stock
2015-03-24$1.97/sh−1,601,390$3,160,183→ 0 total

Ratcliffe Liam

10% Owner

Transactions

Sale
Common Stock
2015-03-24$1.97/sh−1,601,390$3,160,183→ 0 total

New Leaf Venture Associates II, L.P.

10% Owner

Transactions

Sale
Common Stock
2015-03-24$1.97/sh−1,601,390$3,160,183→ 0 total

New Leaf Venture Management II, L.L.C.

10% Owner

Transactions

Sale
Common Stock
2015-03-24$1.97/sh−1,601,390$3,160,183→ 0 total

CHAMBON PHILIPPE

10% Owner

Transactions

Sale
Common Stock
2015-03-24$1.97/sh−1,601,390$3,160,183→ 0 total

Delagardelle Jeani

10% Owner

Transactions

Sale
Common Stock
2015-03-24$1.97/sh−1,601,390$3,160,183→ 0 total

Footnotes (1)

[F1]Represents shares directly beneficially owned by New Leaf Ventures II, L.P. ("NLV II"). New Leaf Venture Associates II, L.P. ("NLV Associates") is the general partner of NLV II and New Leaf Venture Management II, L.L.C. ("NLV Management") is the general partner of NLV Associates. Philippe O. Chambon, Jeani Delagardelle, Ronald Hunt, Vijay Lathi, and Liam Ratcliffe are the individual managers of NLV Management (the "Individual Managers"). NLV Associates and NLV Management disclaim beneficial ownership of such shares, except to the extent of their pecuniary interest therein. As one of five individual managers, each of the Individual Managers disclaims beneficial ownership over the shares reported herein, and in all events disclaims pecuniary interest except to the extent of his economic interest.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

MEI Pharma, Inc.

CIK 0001262104

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001262104

Filing Metadata

Form type: 4
Filed: Mar 25, 8:00 PM ET
Accepted: Mar 26, 4:54 PM ET
Size: 16.7 KB

View on SEC.gov